Abstract :

Numerous studies have examined the effects of the COVID-19 pandemic on women’s mental health and menstrual cycles. However, most of these studies only included outpatients with COVID-19, whereas information on hospitalised women is minimal. ACE 2 is essential for the SAR-CoV2 virus to enter human cells and the human ovary. Since it stimulates steroid secretion, aids in follicle development and oocyte growth, influences ovulation, and maintains the corpus luteum, it stimulates steroid secretion and aids in follicle development and oocyte growth. Hospitalised female COVID-19 patients exhibit menstrual changes and heightened symptoms of mental health disorders. Length of isolation was the most influential factor in overall menstrual changes and mental health in female COVID-19 hospitalised patients. Infection with COVID-19 may affect the menstrual cycle in females. Further prospective research is required to confirm these findings and determine the duration of these menstrual irregularities.

---

Keywords :

ACE2, COVID-19, Follicle development, Menstrual cycle, Sex hormones.

---

References :

1. C. Gotluru, A. Roach, S. H. Cherry, and C. D. Runowicz, “Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)–Related Morbidity,” Obstetrics and gynecology, vol. 137, no. 3, p. 423, 2021.
2. K. Li et al., “Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age,” Reproductive biomedicine online, vol. 42, no. 1, pp. 260-267, 2021.
3. E. E. Ajari, “Why menstrual health and wellbeing promotion should not be sidelined in Africa’s response to COVID-19,” European Journal of Environment and Public Health, vol. 4, no. 2, p. em0045, 2020.
4. P. A. Spagnolo, J. E. Manson, and H. Joffe, “Sex and gender differences in health: what the COVID-19 pandemic can teach us,” vol. 173, ed: American College of Physicians, 2020, pp. 385-386.
5. R. J. Wozniak, D. F. Nixon, and J. L. Marston, “Involvement of Cisgender and transgender individuals in studies on the impact of hormonal therapy on COVID-19,” AIDS patient care and STDs, vol. 34, no. 9, pp. 367-368, 2020.
6. N. Ozimek, K. Velez, H. Anvari, L. Butler, K. N. Goldman, and N. C. Woitowich, “Impact of stress on menstrual cyclicity during the coronavirus disease 2019 pandemic: a survey study,” Journal of Women’s Health, vol. 31, no. 1, pp. 84-90, 2022.
7. M. A. Crane, A. Popovic, A. I. Stolbach, and K. G. Ghanem, “Reporting of sexually transmitted infections during the COVID-19 pandemic,” Sexually transmitted infections, vol. 97, no. 2, pp. 101-102, 2021.
8. C. Carnevale et al., “At home testing for sexually transmitted infections during the COVID-19 pandemic,” Sexually transmitted diseases, vol. 48, no. 1, p. e11, 2021.
9. M. Hod et al., “The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care,” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, vol. 131, pp. S173-S211, 2015.
10. L. C. Poon et al., “The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention,” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, vol. 145, no. Suppl 1, p. 1, 2019.
11. M. A. Hanson et al., “The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition:” Think Nutrition First”,” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, vol. 131, pp. S213-S253, 2015.
12. Y. Jing et al., “Potential influence of COVID-19/ACE2 on the female reproductive system,” Molecular human reproduction, vol. 26, no. 6, pp. 367-373, 2020.
13. G. C. Sharp et al., “The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities,” vol. 51, ed: Oxford University Press, 2022, pp. 691-700.
14. O. Demir, H. Sal, and C. Comba, “Triangle of COVID, anxiety and menstrual cycle,” Journal of Obstetrics and Gynaecology, vol. 41, no. 8, pp. 1257-1261, 2021.
15. V. Male, “Menstrual changes after covid-19 vaccination,” vol. 374, ed: British Medical Journal Publishing Group, 2021.
16. V. Male, “Effect of COVID-19 vaccination on menstrual periods in a retrospectively recruited cohort,” MedRXiv, 2021.
17. G. M. Bwire, “Coronavirus: why men are more vulnerable to Covid-19 than women?,” SN comprehensive clinical medicine, vol. 2, no. 7, pp. 874-876, 2020.
18. J. D. Strope, C. H. Chau, and W. D. Figg, “Are sex discordant outcomes in COVID-19 related to sex hormones?,” 2020, vol. 47: Elsevier, 5 ed., pp. 335-340.
19. T. T. Meng, R. J. Dong, and T. G. Li, “Relationship between COVID-19 and the male reproductive system,” Eur Rev Med Pharmacol Sci, vol. 25, no. 2, pp. 1109-1113, 2021.
20. R. A. Al-Lami, R. J. Urban, E. Volpi, A. M. A. Algburi, and J. Baillargeon, “Sex hormones and novel corona virus infectious disease (COVID-19),” 2020, vol. 95: Elsevier, 8 ed., pp. 1710-1714.
21. R. C. R. Prado, R. Silveira, and R. Y. Asano, “SARS‐CoV‐2 (COVID‐19) pandemic and a possible impact in the future of menstrual cycle research,” Health Science Reports, vol. 4, no. 2, 2021.
22. C. Cattrini, M. Bersanelli, M. M. Latocca, B. Conte, G. Vallome, and F. Boccardo, “Sex hormones and hormone therapy during COVID-19 pandemic: implications for patients with cancer,” Cancers, vol. 12, no. 8, p. 2325, 2020.
23. C. M. Seymen, “The other side of COVID‐19 pandemic: Effects on male fertility,” Journal of medical virology, vol. 93, no. 3, pp. 1396-1402, 2021.
24. E. Ong, M. U. Wong, A. Huffman, and Y. He, “COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning,” Frontiers in immunology, vol. 11, p. 1581, 2020.
25. W. Y. Lee, A. Mok, and J. P. W. Chung, “Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review,” Hong Kong Medical Journal, vol. 27, no. 2, p. 118, 2021.
26. S. S. Patel, J. Kalma, and E. M. Bluman, “Understanding COVID-19 vaccines and their development,” JBJS, vol. 102, no. 20, pp. 1759-1769, 2020.
27. H. A. Raza, P. Sen, O. A. Bhatti, and L. Gupta, “Sex hormones, autoimmunity and gender disparity in COVID-19,” Rheumatology International, vol. 41, no. 8, pp. 1375-1386, 2021.
28. S. Madaan et al., “Post-COVID-19 menstrual abnormalities and infertility: Repercussions of the pandemic,” Journal of Education and Health Promotion, vol. 11, no. 1, p. 170, 2022.
29. A. S. Laganà et al., “Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey,” Open Medicine, vol. 17, no. 1, pp. 475-484, 2022.
30. M. L. Brandi, “Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?,” Reviews in Endocrine and Metabolic Disorders, pp. 1-13, 2021.
31. X.-D. Mao, K.-S. Liu, Y.-P. Yao, and Z.-R. Xu, “Potential effects of COVID-19 on reproductive health: a mini review,” American Journal of Translational Research, vol. 13, no. 12, p. 13321, 2021.
32. Y. He, J. Wang, J. Ren, Y. Zhao, J. Chen, and X. Chen, “Effect of COVID-19 on male reproductive system–a systematic review,” Frontiers in endocrinology, vol. 12, p. 677701, 2021.
33. F. Sheikhzadeh Hesari, S. S. Hosseinzadeh, and M. A. Asl Monadi Sardroud, “Review of COVID‐19 and male genital tract,” Andrologia, vol. 53, no. 1, p. e13914, 2021.
34. M. F. Gröner, R. C. d. Carvalho, J. Camillo, P. R. A. Ferreira, and R. Fraietta, “Effects of Covid-19 on male reproductive system,” International braz j urol, vol. 47, pp. 185-190, 2020.
35. F. Morelli et al., “COVID-19 infection in the human reproductive tract of men and nonpregnant women,” The American journal of tropical medicine and hygiene, vol. 104, no. 3, p. 814, 2021.
36. N. M. Hashem, S. A. Abdelnour, A. R. Alhimaidi, and A. A. Swelum, “Potential impacts of COVID-19 on reproductive health: Scientific findings and social dimension,” Saudi Journal of Biological Sciences, vol. 28, no. 3, pp. 1702-1712, 2021.
37. I. Ramírez et al., “Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia,” Maturitas, vol. 137, pp. 57-62, 2020.
38. N. Mishra et al., “COVID-19 and menstrual status: Is menopause an independent risk factor for SARS Cov-2?,” Journal of Mid-life Health, vol. 11, no. 4, p. 240, 2020.
39. A. Ardestani Zadeh and D. Arab, “COVID-19 and male reproductive system: pathogenic features and possible mechanisms,” Journal of molecular histology, vol. 52, no. 5, pp. 869-878, 2021.
40. A. Edelman et al., “Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: a US Cohort,” Obstetrics & Gynecology, vol. 139, no. 4, pp. 481-489, 2022.
41. S. Dhindsa et al., “Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19,” JAMA network open, vol. 4, no. 5, pp. e2111398-e2111398, 2021.
42. G. Bruinvels, E. Goldsmith, R. C. Blagrove, D. Martin, L. Shaw, and J. Piasecki, “How lifestyle changes within the COVID-19 global pandemic have affected the pattern and symptoms of the menstrual cycle,” medRxiv, 2021.
43. S. C. Okpechi et al., “Global sex disparity of COVID-19: a descriptive review of sex hormones and consideration for the potential therapeutic use of hormone replacement therapy in older adults,” Aging and disease, vol. 12, no. 2, p. 671, 2021.
44. V. Male, “Menstruation and covid-19 vaccination,” vol. 376, ed: British Medical Journal Publishing Group, 2022.
45. T. Ding et al., “Potential influence of menstrual status and sex hormones on female severe acute respiratory syndrome coronavirus 2 infection: a cross-sectional multicenter study in Wuhan, China,” Clinical Infectious Diseases, vol. 72, no. 9, pp. e240-e248, 2021.
46. T. Ding et al., “Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: an observational study,” Frontiers in medicine, p. 286, 2021.
47. H. Motamedi et al., “An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages,” (in eng), Int Immunopharmacol, vol. 96, p. 107763, Jul 2021, doi: 10.1016/j.intimp.2021.107763.
48. N. Phelan, L. A. Behan, and L. Owens, “The impact of the COVID-19 pandemic on women’s reproductive health,” Frontiers in endocrinology, p. 191, 2021.
49. S. Stewart, L. Newson, T. A. Briggs, D. Grammatopoulos, L. Young, and P. Gill, “Long COVID risk-a signal to address sex hormones and women’s health,” The Lancet Regional Health–Europe, vol. 11, 2021.
50. A. Alvergne et al., “COVID-19 vaccination and menstrual cycle changes: A United Kingdom (UK) retrospective case-control study,” MedRXiv, 2021.
51. L. Medina-Perucha et al., “Self-Reported Menstrual Alterations During the COVID-19 Syndemic in Spain: A Cross-Sectional Study,” International Journal of Women’s Health, vol. 14, p. 529, 2022.
52. R. Costeira et al., “Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study,” (in eng), PLoS One, vol. 16, no. 9, p. e0257051, 2021, doi: 10.1371/journal.pone.0257051.
53. S. W. Choi et al., “Hormone Therapy in the Era of the COVID-19 Pandemic: A Review,” Journal of Menopausal Medicine, vol. 28, no. 1, p. 1, 2022.
54. R. Pirhadi, V. S. Talaulikar, J. Onwude, and I. Manyonda, “Could estrogen protect women from COVID-19?,” Journal of clinical medicine research, vol. 12, no. 10, p. 634, 2020.
55. J. H. Lee et al., “Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea,” Menopause (New York, NY), vol. 27, no. 12, p. 1376, 2020.
56. J. L. Stanford, N. S. Weiss, L. F. Voigt, J. R. Daling, L. A. Habel, and M. A. Rossing, “Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women,” Jama, vol. 274, no. 2, pp. 137-142, 1995.
57. X. Xu et al., “Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial,” Clinical and translational medicine, vol. 11, no. 2, p. e297, 2021.
58. T. P. Bouchard, M. Schneider, M. Schmidt, M. Manhart, and R. J. Fehring, “Menstrual Cycle Parameters Are Not Significantly Different After COVID-19 Vaccination,” Journal of Women’s Health, 2022.
59. B. Yuksel and F. Ozgor, “Effect of the COVID‐19 pandemic on female sexual behavior,” International Journal of Gynecology & Obstetrics, vol. 150, no. 1, pp. 98-102, 2020.
60. O. T. Ogunbodede, I. Zablotska-Manos, and D. A. Lewis, “Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections,” Current Opinion in Infectious Diseases, vol. 34, no. 1, pp. 56-61, 2021.